Sergio
Raposeiras Roubín
![Foto de Sergio](/img/nophoto.png)
![Foto de Hospital Universitario de Valladolid](/img/noimage_org.png)
Hospital Universitario de Valladolid
Valladolid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de Valladolid (23)
2024
-
Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort
International Journal of Cardiology, Vol. 405
2023
-
Long-term prognostic impact of beta-blockers in patients with Takotsubo syndrome: Results from the RETAKO Registry
Revista Portuguesa de Cardiologia, Vol. 42, Núm. 3, pp. 237-246
-
The current clinical practice for management of post-infarction ventricular septal rupture: a European survey
European Heart Journal Open, Vol. 3, Núm. 5
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry
Journal of the American Heart Association, Vol. 11, Núm. 13
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries
Frontiers in Cardiovascular Medicine, Vol. 9
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278
-
Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial
European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588
-
Short-term mortality differs between men and women according to the presence of previous cardiovascular disease: Insights from a nationwide STEMI cohort
International Journal of Cardiology, Vol. 367, pp. 90-98
2021
-
Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])
Critical Care Medicine, Vol. 49, Núm. 6, pp. E624-E633
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
Clinical presentation, therapeutic approach, and outcome of young patients admitted for COVID-19, with respect to the elderly counterpart
Clinical and Experimental Medicine, Vol. 21, Núm. 2, pp. 249-268
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry
Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Mortality risk assessment in Spain and Italy, insights of the HOPE COVID-19 registry
Internal and Emergency Medicine, Vol. 16, Núm. 4, pp. 957-966
-
Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry
Emergency Medicine Journal, Vol. 38, Núm. 5, pp. 359-365
-
Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data
Medicina Clinica, Vol. 157, Núm. 7, pp. 318-324
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
American Heart Journal, Vol. 237, pp. 104-115